Sahijoan, Dayang S.
HRN: 07-47-15 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/01/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/01/2022
12/08/2022
IV
1.5g
Q6
CAP MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes